2026 Federal Hemp Ban: What It Means for the Future of Consumable Hemp Products • Vicente LLP

In a sweeping blow to legal consumable hemp industries across the nation, Congress passed a new federal definition of “hemp” on November 12, 2025, which was signed into law by President Donald Trump with a one-year delayed implementation date. 

Under Section 781 of the Appropriations Act for 2026, the federal definition of hemp is set to shift to a total THC standard (0.3% total THC on a dry weight basis, inclusive of THCA and delta-8 THC), and final-form hemp-derived cannabinoid products will additionally be capped at 0.4 mg total THC per container. For a detailed breakdown of the specific statutory changes, see our 2025 Federal Hemp Reclassification Guide. 

Absent intervening legislation, this restrictive standard takes effect on November 12, 2026, rendering approximately 95% of existing hemp-derived cannabinoid products federally unlawful, according to estimates from the U.S. Hemp Roundtable. 

The Impact of Marijuana Rescheduling on Consumable Hemp Products  

Shortly after the Appropriations Act was signed into law, Trump issued an executive order to reschedule marijuana. This order directs the Attorney General to expedite the rescheduling of marijuana from Schedule I to Schedule III, but also requires executive branch officials to work with Congress to update the statutory definition of final hemp-derived cannabinoid products, acknowledging that the current ban language would inadvertently recriminalize full-spectrum nonintoxicating CBD products.  

After months of silence, the DOJ released a final order on April 23, 2026, immediately rescheduling medical marijuana to Schedule III, coupled with an announcement of an expedited administrative process to consider the broader rescheduling of marijuana this summer.  

While the executive order and the slow progress toward effectuating it are a win for the cannabis industry at large, rescheduling does not resolve the hemp ban. In sum, rescheduling affects how the cannabis plant is classified under the Controlled Substances Act, but the hemp ban operates on a separate statutory track with its own distinct federal definition of “hemp.” In other words, rescheduling marijuana and repealing the hemp ban are two distinct actions that require two separate legislative or regulatory solutions to relieve the hemp industry of its November 12, 2026, existential deadline.  

However, in tandem with the April 2026 medical marijuana rescheduling, the Executive Branch has reiterated its desire for Congress to amend the upcoming federal hemp language to preserve access to CBD products, which could signal some hope for at least a partial preservation of the hemp industry. 

What’s Being Done to Stop or Delay the Hemp Ban? 

In the months since Congress brought the federal hammer down on hemp, there have been significant legislative and political efforts to stop, or at least delay, Section 781 from taking effect this November.  

Because the hemp ban was enacted through an appropriations bill rather than standalone legislation, it can technically be modified or overridden through several pathways:  

• A subsequent appropriations bill or the 2026 Farm Bill could amend or repeal Section 781 outright 

• Standalone legislation like the Mace Bill or Hemp Planting Predictability Act could directly alter its terms 

• A comprehensive regulatory framework bill like the HEMP Act (Griffiths Bill) could supersede it entirely.  

While appropriations bills are a procedurally unconventional vehicle for substantive policy changes like this one, they require a different (and often lower) threshold of votes to pass than traditional standalone legislation, meaning the same fast-moving appropriations process that quietly enacted the ban could, in theory, just as quickly undo it. 

Here is where efforts stand on the federal level as of late April 2026, with bills appearing chronologically: 

The Mace Bill: Strike the Ban Entirely 

On November 20, 2025, shortly after the ban’s passage, HR 6209 was introduced in the House by Representative Nancy Mace (R-SC). Dubbed the “American Hemp Protection Act of 2025,” this bill proposes to strike Section 781 in its entirety from the appropriations legislation. If enacted, the definition of hemp would revert to the 2018 Farm Bill standard with no new restrictions or regulations added. 

House & Senate Bills to Delay Implementation 

On January 13, 2026, Representative Jim Baird (R-IN) introduced HR 7024, dubbed the “Hemp Planting Predictability Act” in the House, which would delay implementation by two years, pushing the effective date to November 2028. A Senate companion bill, S. 3686, was introduced on January 15, 2026, by Senators Klobuchar (D-MN), Rand Paul (R-KY), and Jeff Merkley (D-OR). The bill currently has 15 House co-sponsors and has earned public support from the Wine & Spirits Wholesalers of America. 

These companion bills reflect the growing consensus that the November 2026 timeline is too aggressive. 

The Griffith Bill: A Federal Regulatory Framework 

On January 22, 2026, after months of national chatter ahead of its release, HR 7212, commonly known as the “Griffith Bill” or the “HEMP Act,” was formally introduced in the House by Representative H. Morgan Griffith (R-VA). Rather than simply delaying or repealing the ban, this bill, which reportedly received input from the FDA during its drafting, proposes amending the Federal Food, Drug, and Cosmetic Act to establish a comprehensive federal regulatory framework for cannabinoid hemp products. Key requirements would include: 

• Mandatory facility registration with the Secretary of Health and Human Services, with biennial renewal 

• Product listings for each marketed item, including labels, ingredient disclosures, and cannabinoid content 

• Labels must include safety warnings, disclose cannabinoid content, and provide a QR code linking to a Certificate of Analysis 

• Labels may not include imagery appealing to minors 

• Oral products limited to 10mg total / 5mg intoxicating cannabinoids per serving (50 mg and 30 mg per package); inhalable and topical products limited to 100 mg total per serving and 500 mg per package. 

While the Griffith Bill has garnered genuine bipartisan support, Griffith has candidly acknowledged that the bill will likely not move until after the 2026 election cycle and that significant compromise will be required (which is likely why he is also a co-sponsor of the Hemp Planting Predictability Act). This reflects the broader strategy of securing a delay first to buy time and then using that runway to get comprehensive hemp regulation across the finish line. 

The Wyden Bill: FDA Regulation of Hemp-Derived THC 

In early December, Senators Ron Wyden (D-OR) and Jeff Merkley (D-OR) introduced S. 3474, or the “Cannabinoid Safety and Regulation Act.” If enacted, hemp-derived THC products would be federally legal and regulated by the FDA, subject to the following limits: 

• Edibles, topicals, and inhalable products: 5mg THC per serving / 50mg THC per package 

• Beverages: 5mg THC per serving / 10mg THC per package 

• Interstate commerce would be expressly authorized, though states would retain the right to prohibit sales within their borders. 

The Barr Bill: The Lawful Hemp Protection Act 

Although still in its discussion draft stage as of late April 2026, the Lawful Hemp Protection Act, carried by Representative Andy Barr (R-KY), contemplates a comprehensive federal regulatory framework for hemp beverages, with joint oversight from multiple federal agencies: 

A three-tier distribution and permit model similar to that of alcohol would be established under the Alcohol and Tobacco Tax and Trade Bureau (TTB) for hemp-derived beverages 

Hemp-derived consumer products other than beverages would be classified as dietary supplements under FDA purview (although this would create separate legal conflicts for beverages in particular) 

Federal THC threshold would rise from 0.3% to 1%, measured on finished products 

Within 18 months of enactment, the FDA would be required to establish maximum allowable cannabinoid amounts per serving through notice-and-comment rulemaking. 

As circulated, the discussion draft leaves several provisions unsolved, including minimum age of sale and cannabinoid milligram limits, all of which may be subject to negotiation as the bill gains traction in the legislature. 

The 2026 Farm Bill: An Unlikely Avenue Forward 

Industry stakeholders had hoped the 2026 Farm Bill’s consideration this spring could provide a viable vehicle for relief, as it may amend the same section of the U.S. Code containing the prohibitionary hemp language as the Appropriations Bill. However, on March 5, 2026, the House Agriculture Committee voted 34-17 to advance the 2026 Farm Bill after more than 20 hours of markup, but the intoxicating hemp ban emerged completely untouched. 

Rep. Baird filed two amendments (both aimed at delaying the implementation of the hemp ban), but neither was considered. 

Committee Chairman Glenn Thompson (R-PA) determined ahead of the markup that any amendment relating to the hemp ban was not germane to the Farm Bill (arguing the Farm Bill should merely address agriculture, not finished consumable hemp products), placing it outside the committee’s jurisdiction and thus ending the hemp discussion before it could begin. 

Although the Farm Bill then appeared to be a dead end, several new hemp-related amendments were filed in late April 2026, including an amendment from Representative James Comer (R-KY) to delay the implementation date by one year to November 12, 2027, and a regulatory structure amendment from Rep. Barr that was withdrawn shortly after. In an opposite move, Representative Mary Miller (R-IL) filed a late amendment seeking to expedite the ban’s implementation to the date the new Farm Bill is enacted, rather than waiting until this November. 

While the version of the Farm Bill that passed the House on April 28, 2026, contained provisions regarding industrial hemp, the Farm Bill is unlikely to be an effective vehicle for amending the prohibitionary hemp language regarding final-form products. Even though Chairman Thompson no longer has full jurisdiction over the bill once it leaves committee, his assertion that hemp amendments are not germane to the bill carries significant weight as the bill’s chief sponsor as it progresses through the rest of the legislative process. 

States’ Rights Bill: The Hemp Safety Enforcement Act 

Introduced on April 16, 2026, by Senators Paul, Klobuchar, and Ernst (R-IA), the Hemp Safety Enforcement Act seeks to amend the Agricultural Marketing Act of 1946 to create a state and tribal opt-out mechanism from the federal hemp regulatory framework. The bill, designed to take effect at the same time as the Appropriations Bill (November 12, 2026), would operate alongside, rather than in place of, the impending definitional change of hemp. Key provisions of the bill include: 

• A state or tribal jurisdiction may file a notice with USDA electing not to be subject to the federal hemp subtitle 

• An opt-out state would be released from federal production rules, USDA plan requirements, and the federal definition of “hemp,” and may substitute its own definitions of “hemp” and “hemp-derived cannabinoid product” under State law 

• The only substantive federal floors preserved for opt-out states are (1) the requirement to implement a minimum age for purchase of hemp-derived cannabinoid products (no specific age is prescribed), and (2) the exclusion of final products containing cannabinoids not capable of being naturally produced by the cannabis plant. 

If enacted, the bill would allow states to circumvent the pending federal prohibition, define “hemp” at the state level, and maintain their own hemp markets. As of late early May 2026, the bill is pending further consideration in the legislature. 

Where Does the Hemp Industry Go from Here? 

With the November 12, 2026, deadline now less than six months away, the window for legislative intervention is narrowing fast, and the path forward remains anything but certain. Rectifying the ban through the 2026 Farm Bill is unlikely, and the standalone bills most likely to provide relief still face an uphill climb in a divided and distracted Congress. Some state lawmakers are moving quickly to pass legislation to preserve state-level hemp markets, while others are taking steps to align their jurisdictions with the impending federal restrictions. 

Hemp stakeholders remain in a precarious spot as the future of their industry remains uncertain. While some operators may choose to take a step back, others, like Target, appear to have more confidence, as the retail giant continues to expand its hemp retail licensure in Minnesota despite the looming prohibition.  

For more information on how to navigate these impending federal changes, geared specifically for hemp beverage stakeholders, see our article How to Prepare for the Federal Hemp Ban: 12 Strategic Routes for Hemp Beverage Stakeholders. 

Whether relief comes through a delay, a regulatory framework, or a future appropriations vehicle, one thing is clear: stakeholders across the hemp supply chain cannot afford to wait and see. The decisions being made in Washington right now will ultimately determine the future of a multi-billion-dollar American industry. 

Vicente LLP’s hemp and cannabinoid regulatory attorneys are actively tracking the federal hemp ban and legislative updates. Contact our team with questions about the impact of this bill and its implications for the future of the hemp industry. 

Texas’s consumable hemp market now faces a stricter DSHS testing standard for Total THC (inclusive of THCA) with steep fee increases and the reinstatement of 2021 definitions placing most converted…

Texas synthetic cannabinoids are once again Schedule I controlled substances. In the July 10, 2026 edition of the Texas Register, the Texas Department of State Health Services (DSHS) published a…

North Carolina’s HB 328 hemp bill awaits a House vote after summer recess. Learn what the total-THC standard and 0.4mg cap mean for operators.